Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial
Disclaimer: Publications may either be freely available or require a fee to view (or access) on the journal’s website.
Full Citation
Nourbakhsh B, Revirajan N, Morris B, Cordano C, Creasman J, Manguinao M, Krysko K, Rutatangwa A, Auvray C, Aljarallah S, Jin C, Mowry E, McCulloch C, Waubant E. Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial. Lancet Neurol. 2020 Nov 23:S1474-4422(20)30354-9. doi: 10.1016/S1474-4422(20)30354-9. Epub ahead of print. PMID: 33242419.
Tags
Journal Article Type
- Paper Resulting From PCORI-Funded Research Study (with results)
- CER Results
Journal Publication Name
- Lancet Neurology
Literature Type
- PCORI Research